SecBot SecBot
8-K ·Filed Aug 3, 2026

STOK

Stoke Therapeutics, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed3mo ago SEC0001193125-26-330804
8-K context-dependent: Items 8.01
Actionable Insight ▼ Bearish

Expect near-term stock pressure as the ATM is drawn down; watch daily volume and price action for accelerated selling. The overhang will persist until the full $200M is utilized or the ATM is terminated. No fundamental catalyst offsets this dilution.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$31.67
T+0 close · Aug 3, 2026 · via day close
Latest settled
−17.49%
T+60 · $26.13
Vs SPY
−17.28%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 4 $31.67entry
  2. T+1 · 3mo ago +0.82%α +1.02% · $31.93
  3. T+5 · 3mo ago +4.07%α +4.17% · $32.96
  4. T+20 · 3mo ago −2.46%α −1.22% · $30.89
  5. T+60 · 20d ago −17.49%α −17.28% · $26.13
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Stoke Therapeutics filed a prospectus supplement to sell up to $200 million of common stock in an at-the-market (ATM) offering through Cantor Fitzgerald. At a $1.8B market cap, this represents ~11% potential dilution, creating near-term selling pressure and a clear negative signal for existing shareholders.

Key Facts

  • On August 3, 2026, Stoke filed a prospectus supplement under its existing Sales Agreement with Cantor Fitzgerald for an ATM offering of up to $200 million in common stock.
  • The offering is made under the Company's automatic shelf registration statement on Form S-3ASR (File No. 333-294402) filed March 18, 2026.
  • Shares may be sold from time to time at market prices, with no fixed timetable or minimum price.

Financial Impact

Up to $200M in new equity, equivalent to ~11% of the $1.8B market cap, resulting in material dilution to existing shareholders.

dilutionshares outstandingearnings per share

Risk Factors

  • Dilution of ~11% if the full $200M is issued at current prices
  • Ongoing overhang from continuous ATM sales may cap upside
  • Possible negative signal to market about near-term cash needs

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-330804
Document: d135735dex51.htm0001193125-26-330804
Document: 0001193125-26-330804-index-headers.html0001193125-26-330804
Document: 0001193125-26-330804-index.html0001193125-26-330804
Document: 0001193125-26-330804.txt0001193125-26-330804

Track record

18 reports on STOK

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +17.49% at T+60 after the Aug 3, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $27.02 Now $26.63 −1.44% settles Feb 12
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  4. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $26.12 Now $26.63 +1.95% settles Feb 12
  5. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $26.07 Now $26.63 +2.15% settles Feb 3
  6. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $26.29 Now $26.63 +1.29% settles Jan 28
  7. Oct 21, 202626d ago 144 Bearish 6/10 Entry $25.70 Now $26.63 −3.62% settles Jan 20
  8. Sep 30, 20266w ago SC 13G Neutral 4/10 Entry $26.01 Now $26.63 +2.38% settles Dec 28
  9. Sep 25, 20267w ago 8-K Neutral 2/10 Entry $25.50 Now $26.63 +4.43% settles Dec 22
  10. Aug 18, 202612w ago Insider Cluster Neutral 3/10 Entry $33.03 to $26.20 Now $26.63 −19.38% ▼ −20.68% −19.13% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens Wed (10h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 3, 2026